A randomised phase one clinical trial conducted by scientists and doctors from Shanghai and Guangzhou has achieved encouraging results in the treatment of Type 1 diabetes using stem cells extracted from gum tissue.
More than half of those who received the treatment showed varying degrees of improvement, while one subject was able to discontinue exogenous insulin therapy completely, the researchers said.
Results of the study, which tested a therapy based on gingival mesenchymal stem cells (GMSC),...
China trial shows gum tissue stem cells help 55% of lifetime diabetes patients
Global - Asia
Archived
•
October 27, 2026
•
Source: South China Morning Post | https://www.scmp.com/rss/91/feed - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



